Apotea (APOTEA) — Cash Flow Reinvestment Rate
Latest as of June 2026:
0.04x
Apotea (APOTEA) has a Cash Flow Reinvestment Rate of 0.04x as of June 2026, reinvesting Skr2.90 Million (capex Skr2.90 Million ) from operating cash flow of Skr76.80 Million. See APOTEA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.04x
(Capex + Investments) / Operating CF
Total Reinvested
Skr2.90 Million
Capex + Investments
Operating Cash Flow
Skr76.80 Million
SEK
Capital Expenditures
Skr2.90 Million
SEK
Apotea Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Apotea across 5 annual periods. For the full cash flow conversion analysis, see APOTEA cash flow conversion.
Annual Cash Flow Reinvestment Rate for Apotea (2021–2025)
Year-by-year capital reinvestment analysis for Apotea. See APOTEA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.65x | Skr215.60 Million | Skr333.30 Million | Skr215.60 Million | ▼ -18.6% |
| 2024 | 0.79x | Skr163.90 Million | Skr206.20 Million | Skr163.80 Million | ▲ +40.9% |
| 2023 | 0.56x | Skr121.70 Million | Skr215.80 Million | Skr121.10 Million | ▼ -88.1% |
| 2022 | 4.73x | Skr149.10 Million | Skr31.50 Million | Skr142.10 Million | ▲ +1220.5% |
| 2021 | 0.36x | Skr81.48 Million | Skr227.30 Million | Skr81.48 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow